T. Fukasawa

发表

A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans.

L. Milani, L. Gustafsson, J. Ogwal-okeng, 2009, British journal of clinical pharmacology.

Relation between drug-induced taste disorder and chelating behavior with zinc ion; statistical approach to the drug-induced taste disorder, part II.

Y. Kanzaki, T. Fukasawa, Masayo Tanaka, 2008, Chemical & pharmaceutical bulletin.

Statistical approach to drug-induced taste disorders based on zinc chelating ability.

Y. Kanzaki, T. Fukasawa, Masayo Tanaka, 2005, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

A successful clonazepam treatment without tolerance in a patient with spontaneous oral dyskinesia

K. Otani, Michihiro Takahashi, T. Fukasawa, 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Neuroleptic malignant syndrome complicated by massive intestinal bleeding in a patient with chronic renal failure

K. Otani, S. Kawakatsu, Kyota Watanabe, 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Single Oral Dose Pharmacokinetics of Quazepam Is Influenced by CYP2C19 Activity

K. Otani, A. Suzuki, T. Tateishi, 2004, Therapeutic drug monitoring.

Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism

K. Otani, A. Suzuki, Y. Inoue, 2004, European Journal of Clinical Pharmacology.

Effects of Caffeine on the Kinetics of Fluvoxamine and its Major Metabolite in Plasma After a Single Oral Dose of the Drug

K. Otani, A. Suzuki, Y. Inoue, 2006, Therapeutic drug monitoring.

Rifampicin Markedly Decreases Plasma Concentration and Hypnotic Effect of Brotizolam

K. Otani, A. Suzuki, T. Tateishi, 2006, Therapeutic drug monitoring.

Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity

K. Otani, A. Suzuki, Y. Inoue, 2005, European Journal of Clinical Pharmacology.

Inhibition of the metabolism of brotizolam by erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in brotizolam metabolism.

K. Otani, A. Suzuki, Y. Inoue, 2005, British journal of clinical pharmacology.

Interaction Study Between Enoxacin and Fluvoxamine

K. Otani, A. Suzuki, Y. Inoue, 2005, Therapeutic drug monitoring.

Interaction Study between Fluvoxamine and Quazepam

K. Otani, A. Suzuki, T. Fukasawa, 2003, Journal of clinical pharmacology.

Effects of Itraconazole on the Plasma Kinetics of Quazepam and Its Two Active Metabolites after a Single Oral Dose of the Drug

K. Otani, A. Suzuki, T. Fukasawa, 2003, Therapeutic drug monitoring.

Effects of the CYP2C19 genotype and cigarette smoking on the single oral dose pharmacokinetics and pharmacodynamics of estazolam

M. Miura, K. Otani, Y. Otsuji, 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

No Effect of Itraconazole on the Single Oral Dose Pharmacokinetics and Pharmacodynamics of Estazolam

M. Miura, K. Otani, Y. Otsuji, 2002, Therapeutic drug monitoring.

Monoamine oxidase A gene promoter polymorphism affects novelty seeking and reward dependence in healthy study participants

K. Otani, A. Suzuki, T. Fukasawa, 2006, Psychiatric genetics.

Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines

K. Otani, A. Suzuki, T. Fukasawa, 2007, Journal of clinical pharmacy and therapeutics.

N‐acetyltransferase‐2 (NAT2) Gene Polymorphisms and Enzyme Activity in Serbs: Unprecedented High Prevalence of Rapid Acetylators in a White Population

S. Janković, G. Gervasini, N. Ueda, 2011, Journal of clinical pharmacology.

Effects of the CYP 2D6 Genotype and Cigarette Smoking on the Steady‐State Plasma Concentrations of Fluvoxamine and Its Major Metabolite Fluvoxamino Acid in Japanese Depressed Patients

K. Otani, H. Higuchi, Keizo Yoshida, 2003, Therapeutic drug monitoring.

Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients

K. Otani, H. Higuchi, Keizo Yoshida, 2003, Psychopharmacology.

Induction of the metabolism of etizolam by carbamazepine in humans

K. Otani, A. Suzuki, Y. Inoue, 2005, European Journal of Clinical Pharmacology.

No association between the TPH A218C polymorphism and personality traits in Japanese healthy subjects

K. Otani, A. Suzuki, T. Fukasawa, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Prescribing Trends for the Same Patients with Schizophrenia Over 20 Years

Norio Sugawara, K. Shimoda, Kensuke Miyazaki, 2023, Neuropsychiatric disease and treatment.

A three‐factor model of the MADRS in major depressive disorder

K. Otani, A. Suzuki, H. Higuchi, 2005, Depression and anxiety.